Annexon, Inc. (ANNX)

Annexon, Inc. (ANNX) — VMCI valuation read

Across 120 indicators, Annexon, Inc. (ANNX) lands at VMCI 36/100. The Healthcare sector median is 50, so the 14-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on ANNX in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, ANNX trades at 19.0x earnings, 6% above the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 17.0% sits 7.0pp above the Healthcare median (10.0%). On Risk, net debt to EBITDA of 2.3x is the rate-sensitivity line to watch for ANNX on the trailing balance sheet.

ANNX fell 1.7% over the trailing 7 days, with a -23.9% read on a 30-day basis.